Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Novartis
National Institutes of Health Clinical Center (CC)
Takeda
Center for International Blood and Marrow Transplant Research
Crossbow Therapeutics, Inc.
Masonic Cancer Center, University of Minnesota
Novartis
University of California, Irvine
Hackensack Meridian Health
Massachusetts General Hospital
Novartis
Novartis
Groupe Francophone des Myelodysplasies
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Gamida Cell ltd
Ossium Health, Inc.
Dartmouth-Hitchcock Medical Center
Children's Hospital Medical Center, Cincinnati